One proposed mechanism of induced apoptosis and slow cell growth is the action of carfilzomib with CUR to suppress the NF-κB pathway of the MM cell cycle (Allegra et al., 2018). The gene discussed is NFKB1; the disease is Miyoshi myopathy.